June 16, 2020 Edition
COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.
In patients with COVID-19, off-label use of a cancer drug reduced respiratory distress and over-reactive immune responses. The results were used to inform the design of a clinical trial
|
People with abnormal clusters of blood vessels in the brain called cavernous angiomas had differences in their gut bacteria. The findings could help lead to new diagnostic tests and treatments.
|
Researchers created hair-growing skin from human stem cells and successfully grafted it to mice.
|
Popular Stories
|
No hay comentarios:
Publicar un comentario